Insulin Resistance, Metabolic Diseases and Diabetic Complications
Proceedings of the 7th European Symposium on Metabolism, Padova, 30 September - 3 October, 1998
Seiten
1999
Elsevier Science Ltd (Verlag)
978-0-444-50022-9 (ISBN)
Elsevier Science Ltd (Verlag)
978-0-444-50022-9 (ISBN)
- Titel ist leider vergriffen;
keine Neuauflage - Artikel merken
Hardbound. Insulin resistance was recognized as a feature and a pathogenic mechanism in pathological states such as type 2 diabetes mellitus and obesity. More recently, however, it has become apparent that an impairment in insulin action is shared by a variety of conditions not necessarily associated with diabetes or obesity. These conditions include essential hypertension, dyslipidemia, endothelial dysfunction, hyperuricemia and many others. Moreover, these conditions tend to cluster with insulin resistance prompting the definition of the Syndrome of Insulin Resistance. This association has been recently recognized by the WHO as a tentative definition of diagnostic criteria was proposed. This book provides a comprehensive information on the role of insulin resistance as prognostic parameter.This book collects the contribution of the most eminent experts in the field of genetics, epidemiology, physiopathology, complications and therapy of insulin r
Erscheint lt. Verlag | 16.7.1999 |
---|---|
Reihe/Serie | International Congress S. ; v. 1177 |
Zusatzinfo | Illustrations |
Verlagsort | Oxford |
Sprache | englisch |
Gewicht | 665 g |
Themenwelt | Medizinische Fachgebiete ► Innere Medizin ► Endokrinologie |
Studium ► 1. Studienabschnitt (Vorklinik) ► Biochemie / Molekularbiologie | |
ISBN-10 | 0-444-50022-7 / 0444500227 |
ISBN-13 | 978-0-444-50022-9 / 9780444500229 |
Zustand | Neuware |
Haben Sie eine Frage zum Produkt? |
Mehr entdecken
aus dem Bereich
aus dem Bereich
Buch | Softcover (2023)
Urban & Fischer in Elsevier (Verlag)
CHF 69,95